[ Price : $8.95]
HHS Office of Inspector General abolishes a controversial memorandum of understanding that allowed FDAs Office of Internal Affairs...[ Price : $8.95]
FDA tentatively approves a Caraco Pharmaceutical Laboratories ANDA for a generic copy of GlaxoSmithKlines Lamictal (lamotrigine) t...[ Price : $8.95]
Health Canada restricts most monotherapy and combination uses of GlaxoSmithKlines Avandia.[ Price : $8.95]
Cephalon submits an sNDA to FDA for a Fentora indication for managing breakthrough pain in opioid tolerant patients.[ Price : $8.95]
Federal Register Notice: FDA publishes a list of approved CBER PMAs and announces the availability of their safety and effectivene...